Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications

<p dir="ltr">Triple-negative breast cancer (TNBC) accounts for ~15–20% of breast cancer (BC) and has a higher rate of early relapse and mortality compared to other subtypes. The Chemokine (C-C motif) ligand 5 (CCL5) and its signaling pathway have been linked to TNBC. We aimed to inve...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Jingxuan Shan (4711089) (author)
مؤلفون آخرون:	Aziz Chouchane (8089028) (author), Younes Mokrab (6367) (author), Mohamad Saad (214545) (author), Salha Boujassoum (8089031) (author), Rosalyn W. Sayaman (8089034) (author), Elad Ziv (1263) (author), Noureddine Bouaouina (61837) (author), Yasmine Remadi (8089037) (author), Sallouha Gabbouj (8089040) (author), Jessica Roelands (7516439) (author), Xiaojing Ma (44943) (author), Davide Bedognetti (2632474) (author), Lotfi Chouchane (61840) (author)
منشور في:	2019
الموضوعات:	Biomedical and clinical sciences Oncology and carcinogenesis CCL5 CCL5 signaling genes triple negative breast cancer prognosis susceptibility
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications

مواد مشابهة